What is the total market value of Glycomics Market report?

 


Expected Revenue Growth:

[173 Pages Report] The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

What This Report Will Provide?

This study involved four major activities in estimating the current size of the glycomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The bottom-up approach was employed to estimate the size of the market.

Major Growth Boosters:

The growth of this market is majorly driven by the increasing R&D expenditure and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics instrumentation are the major factors driving the growth of the glycomics market.

Regional Growth Analysis:

The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global glycomics market, followed by Europe. The largest share of North America is mainly attributed to increasing funding on glycomics research, rising R&D expenditure for drug discovery & development, and the presence of all key players.

Key Market Players

The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).

Recent Developments

·         Agilent Technologies (US) has launched InfinityLab LC/MSD iQ System

·         Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.

Key Questions Addressed by the Report

1.       Where will all these developments take the industry in the mid-to-long term?

2.       What are the recent trends affecting the glycomics market?

3.       Who are the key players in the market, and how intense is the competition?

4.       What are the key applications of glycomics?

5.       Which region is lucrative for the market?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

Comments

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™

Sterilization Services Market worth $5.49 billion by 2030